Mucormycosis in COVID-19 Patients: A Case-Control Study

(1) Background: During the second wave of COVID-19, India faced a rapid and sudden surge of not only COVID19-delta variant cases but also mucormycosis, making the infection even more fatal. We conducted a study to determine factors associated with the occurrence of mucormycosis in patients with COVI...

Full description

Bibliographic Details
Published in:Microorganisms
Main Authors: Awadh Kishor Pandit, Poorvi Tangri, Shubham Misra, Madakasira Vasantha Padma Srivastava, Sushma Bhatnagar, Alok Thakar, Kapil Sikka, Smriti Panda, Venugopalan Y. Vishnu, Rajesh Kumar Singh, Animesh Das, Divya M. Radhakrishnan, Achal Kumar Srivastava, Rajeshwari Subramaniam, Anjan Trikha, Ayush Agarwal, Roopa Rajan, Vibhor Upadhyay, Sathish Parikipandla, Anup Singh, Arvind Kairo
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Subjects:
mucormycosis COVID-19
intracranial fungal infection
COVID-19
Online Access:https://www.mdpi.com/2076-2607/10/6/1209

Internet

https://www.mdpi.com/2076-2607/10/6/1209

Similar Items